Acute treatment of bipolar disorder with adjunctive risperidone in outpatients.

@article{Ghaemi1997AcuteTO,
  title={Acute treatment of bipolar disorder with adjunctive risperidone in outpatients.},
  author={Seyyed Nassir Ghaemi and Gary S. Sachs and Claudia F Baldassano and Christine J Truman},
  journal={Canadian journal of psychiatry. Revue canadienne de psychiatrie},
  year={1997},
  volume={42 2},
  pages={196-9}
}
OBJECTIVE To test the hypothesis that, although typical neuroleptics are commonly used in the treatment of bipolar disorder, newer atypical antipsychotic agents, like risperidone, may be more effective and better-tolerated. METHOD The effectiveness of risperidone was evaluated in 14 outpatients with bipolar disorder, type I, who received risperidone for 6.4 +/- 2.7 weeks at 2.75 +/- 1.8 mg/day. RESULTS Nine (64%) patients were much improved based on Clinical Global Impression (CGI) scores… CONTINUE READING